Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
141 hedge funds and large institutions have $795M invested in Immunogen Inc in 2014 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 36 reducing their positions, and 16 closing their positions.
209% more call options, than puts
Call options by funds: $7.11M | Put options by funds: $2.3M
42% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 36
25% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 16
3% more funds holding
Funds holding: 137 → 141 (+4)
10% less capital invested
Capital invested by funds: $887M → $795M (-$92.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$19.1M |
| 2 |
ClearBridge Investments
New York
|
+$11.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$10.5M |
| 4 |
PA
Pinnacle Associates
New York
|
+$4.51M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.6M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$15.2M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$10.7M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.63M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.16M |
IMGN Hedge Fund Activity: Q3 2014 in Review
141 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2014, worth a combined $795M — down 10% from $887M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new IMGN positions and 16 closed out — a net gain of 4 holders — while 51 added to existing stakes and 36 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $19.1M. The largest seller was Fidelity Investments, cutting an estimated $15.6M.
- 141 institutional investors held Immunogen Inc (IMGN) as of Q3 2014, up from 137 in Q2 2014.
- Funds reported $795M of Immunogen Inc stock for Q3 2014, down 10% quarter-over-quarter.
- 20 funds opened new Immunogen Inc positions in Q3 2014 and 16 closed out, a net change of +4 holders.
- The largest Immunogen Inc buyer in Q3 2014 was First Trust Advisors, an estimated $19.1M added.
- The largest Immunogen Inc seller in Q3 2014 was Fidelity Investments, an estimated $15.6M sold.
Based on aggregated 13F filings for Q3 2014.